PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2003 December; 4(4): 561–564.
Published online 2003 November 13. doi:  10.1208/pt040470
PMCID: PMC2750663

Design of rapidly disintegrating oral tablets using acid-treated yeast cell wall: A technical note

Full Text

The Full Text of this article is available as a PDF (289K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Kaneko K, Kanada K, Ouchi K, Saito N, Ozeki T, Yuasa H, Kanaya Y. Control of drug release from granules coated with sodium alginate and calcium lactate through insoluble gel formation. J Pharm Sci Technol. Jpn. 1999;59:8–16.
2. Watanabe K, Yakou S, Takayama K, Machida Y, Nagai T. Drug release behaviors from hydrogel prepared with water soluble dietary fibers. J Pharm Sci Technol, Jpn. 1991;51:29–35.
3. Ashford M, Fell J, Atwood D, Sharma H, Woodhead P. Studies on pectin formulation for colonic drug delivery. J Control Release. 1994;30:225–232. doi: 10.1016/0168-3659(94)90028-0. [Cross Ref]
4. Hou W, Miyazaki S, Takada M. Intragastric-floating and sustained-release tablets using chitosan and chitosan hydrochloride. J Pharm Sci Technol, Jpn. 1991;51:93–99.
5. Kasai T, Eguchi T, Ishiwaki N, Kaneshige J, Ozeki T, Yuasa H. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive I: AYC as a novel coating material. Int J Pharm. 2000;204:53–59. doi: 10.1016/S0378-5173(00)00465-8. [PubMed] [Cross Ref]
6. Yuasa H, Kaneshige J, Ozeki T, Kasai T, Eguchi T, Ishiwaki N. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive II: effects of curing on the medicine release from AYC-coated tablets. Int J Pharm. 2000;209:69–77. doi: 10.1016/S0378-5173(00)00555-X. [PubMed] [Cross Ref]
7. Yuasa H, Kaneshige J, Ozeki T, Kasai T, Eguchi T, Ishiwaki N. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive III: AYC aqueous coating onto granules and film formation mechanism of AYC. Int J Pharm. 2002;237:15–22. doi: 10.1016/S0378-5173(02)00008-X. [PubMed] [Cross Ref]
8. Yuasa H, Katsuyama H, Ozeki T, Takashima Y, Okada H, Kasai T, Eguchi T, Kakiuchi H. Acid-treated yeast cell wall (AYC) as a novel binder. J Pharm Sci Technol, Jpn. 2002;62:153–160.
9. Ozeki T, Katsuyama H, Takashima Y, Kasai T, Eguchi T, Kakiuchi H, Yuasa H, Okada H. Acid-treated yeast cell wall (AYC) as a binder displaying function of disintegrant.AAPS PharmSciTech. 2003;4(3): article 41. [PMC free article] [PubMed]
10. Bi Y, Yonezawa Y, Sunada H. Rapidly disintegrating tablets prepared by the wet compression method: mechanism and optimization. J Pharm Sci. 1999;88:1004–1010. doi: 10.1021/js990061z. [PubMed] [Cross Ref]
11. Bi Y, Sunada H, Yonezawa Y, Danjo K. Evaluation of rapidly disintegrating tablets prepared by direct compression method. Drug Dev Ind Pharm. 1999;25:571–581. doi: 10.1081/DDC-100102211. [PubMed] [Cross Ref]
12. Shu T, Suzuki H, Hironaka K, Ito K. Studies of rapidly disintegrating tablets in the oral cavity using co-grinding mixtures of mannitol with crospovidone. Chem Pharm Bull. 2002;50:193–198. doi: 10.1248/cpb.50.193. [PubMed] [Cross Ref]
13. Schiermeier S, Schmidt PC. Fast dispersible ibuprofen tablets. Eur J Pharm Sci. 2002;15:295–305. doi: 10.1016/S0928-0987(02)00011-8. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists